Core Viewpoint - The U.S. Federal Circuit Court confirmed the validity of certain claims of U.S. Patent No. 10,702,385 owned by Cardiovalve Ltd., which relates to heart valve implants, amidst challenges from Edwards Lifesciences Corp. and Edwards Lifesciences LLC [1] Group 1 - Cardiovalve Ltd. filed a patent infringement lawsuit against Edwards on January 14, 2026, in the U.S. District Court for the District of Delaware, alleging that Edwards' core product, the PASCAL Precision transcatheter valve repair system, infringes on the U.S. Patent No. 10,702,385 [1] - The lawsuit is still in its preliminary stages, and further details, including potential claims for damages, will depend on the outcome of the litigation [1] - The company will make further announcements regarding any substantial developments in the lawsuit in accordance with the rules of the Hong Kong Stock Exchange [1]